Skip to content

Clinical trials

Recruiting Carcinoma, Renal Cell trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Renal Cell Status: Recruiting Country / region: China Clear all

63 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20171
20181
20191
20212
20224
20235
202417
202520
202612

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting63

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Jinling Hospital, China7
Peking University First Hospital6
Sun Yat-sen University5
RenJi Hospital3
Shao Pengfei3
Tianjin Medical University Second Hospital3
Fudan University2
Peking University Third Hospital2
The First Affiliated Hospital with Nanjing Medical University2
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Renal Cell63
Kidney Neoplasms17
Carcinoma, Non-Small-Cell Lung7
Carcinoma, Hepatocellular4
Ovarian Neoplasms4
Uterine Cervical Neoplasms4
Carcinoma3
Colorectal Neoplasms3
Neoplasm Metastasis3
Small Cell Lung Carcinoma3

Trials

Showing 1 to 25 of 63. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.